About
Innovative business leader and 2022 Inc Magazine Female Founder with expertise in advancing healthcare diagnostics. Brings extensive experience with FDA submissions across 510(k), PMA, and CLIA LDT regulatory pathways, as well as directing teams launching paradigm-changing diagnostics across Europe, the Middle East, Latin America, and Asia.
Experience
- AOA DxChief Regulatory Officer and Co-foundercurrent2020 — present
- Scipher MedicineDirector Of Business Development2018 — 2020Greater Boston Area
- QIAGENDirector, International Business Development2018
- Parsagen Diagnostics, Inc.Director, International Business Development2015 — 2018Greater Boston Area
- QIAGENProject Manager, Commercial Partners, Europe, Middle East & Africa2013 — 2015Düsseldorf Area, Germany
- QIAGENManager, International Business Development2010 — 2013Greater Boston Area
Education
- Y Combinator2021
- Questrom School of Business, Boston UniversityBS, International Management and Finance
Skills & more
Strategic Planning9Negotiation1Strategy13ManagementLeadershipInternational Management3International Business1Product Marketing3Medical Devices9Competitive Analysis9Business Strategy5Market Research11
+12 more
Business DevelopmentProduct DevelopmentHealthcareSales ManagementNew Business DevelopmentStart-upsMarketing StrategyProduct LaunchProduct ManagementCross-functional Team LeadershipBusiness PlanningCRMLanguages English · Russian
From Anna's professional profile.
Colleagues at AOA Dx
Abby McElhinny
Chief Scientific Officer at AOA Dx
Alex Fisher
Chief Operating Officer & Co-Founder at AOA Dx
Cory Bystrom
Senior Director, Biomarker & Analytical Development at AOA Dx
Drew Watson
Clinical Advisor at AOA Dx
Elizabeth Yarber
Senior Director of Clinical Operations at AOA Dx
Emily Chang
Director, R&D at AOA Dx
James White
Scientific Advisor at AOA Dx
John Friedman
Board Member at AOA Dx